Erratum: Regulation of Axon Degeneration after Injury and in Development by the Endogenous Calpain Inhibitor Calpastatin (Neuron (2013) 80(5) (1175–1189), (S0896627313007939), (10.1016/j.neuron.2013.08.034));Regulation of axon degeneration after injury and in development by the endogenous calpain inhibitor calpastatin

Neuron

Volumn 80, Issue 5, 2013, Pages 1175-1189

  Yang, Jing ^a,b   Weimer, Robby M ^b   Kallop, Dara ^b   Olsen, Olav ^a,b   Wu, Zhuhao ^a   Renier, Nicolas ^a   Uryu, Kunihiro ^a   Tessier Lavigne, Marc ^a,b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CALPASTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; BINOCULAR CONVERGENCE; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NERVE CELL DIFFERENTIATION; NERVE FIBER DEGENERATION; NERVE FIBER TRANSECTION; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; RETINA GANGLION CELL; SENSORY NERVE CELL;

EID: 84888881065     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2023.10.028     Document Type: Erratum

References (54)

1. Araújo I.M., Carvalho C.M. Role of nitric oxide and calpain activation in neuronal death and survival. Curr. Drug Targets CNS Neurol. Disord. 2005, 4:319-324.
2. Bano D., Young K.W., Guerin C.J., Lefeuvre R., Rothwell N.J., Naldini L., Rizzuto R., Carafoli E., Nicotera P. Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity. Cell 2005, 120:275-285.
3. Barrientos S.A., Martinez N.W., Yoo S., Jara J.S., Zamorano S., Hetz C., Twiss J.L., Alvarez J., Court F.A. Axonal degeneration is mediated by the mitochondrial permeability transition pore. J.Neurosci. 2011, 31:966-978.
4. Blomgren K., Hallin U., Andersson A.L., Puka-Sundvall M., Bahr B.A., McRae A., Saido T.C., Kawashima S., Hagberg H. Calpastatin is up-regulated in response to hypoxia and is a suicide substrate to calpain after neonatal cerebral hypoxia-ischemia. J.Biol. Chem. 1999, 274:14046-14052.
5. Burke R.E., O'Malley K. Axon degeneration in Parkinson's disease. Exp. Neurol. 2012.
6. Camins A., Verdaguer E., Folch J., Pallàs M. Involvement of calpain activation in neurodegenerative processes. CNS Drug Rev. 2006, 12:135-148.
7. Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci. 2005, 6:889-898.
8. Coleman M.P., Freeman M.R. Wallerian degeneration, wld(s), and nmnat. Annu. Rev. Neurosci. 2010, 33:245-267.
9. Croall D.E., DeMartino G.N. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol. Rev. 1991, 71:813-847.
10. Crocker S.J., Smith P.D., Jackson-Lewis V., Lamba W.R., Hayley S.P., Grimm E., Callaghan S.M., Slack R.S., Melloni E., Przedborski S., et al. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J.Neurosci. 2003, 23:4081-4091.
11. D'Orsi B., Bonner H., Tuffy L.P., Düssmann H., Woods I., Courtney M.J., Ward M.W., Prehn J.H. Calpains are downstream effectors of bax-dependent excitotoxic apoptosis. J.Neurosci. 2012, 32:1847-1858.
12. De Vos K.J., Grierson A.J., Ackerley S., Miller C.C. Role of axonal transport in neurodegenerative diseases. Annu. Rev. Neurosci. 2008, 31:151-173.
13. Feldheim D.A., O'Leary D.D. Visual map development: bidirectional signaling, bifunctional guidance molecules, and competition. Cold Spring Harb. Perspect. Biol. 2010, 2:a001768.
14. Garcia-Frigola C., Carreres M.I., Vegar C., Herrera E. Gene delivery into mouse retinal ganglion cells by in utero electroporation. BMC Dev. Biol. 2007, 7:103.
15. George E.B., Glass J.D., Griffin J.W. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J.Neurosci. 1995, 15:6445-6452.
16. Gilley J., Coleman M.P. Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol. 2010, 8:e1000300.
17. Glass J.D., Culver D.G., Levey A.I., Nash N.R. Very early activation of m-calpain in peripheral nerve during Wallerian degeneration. J.Neurol. Sci. 2002, 196:9-20.
18. Goll D.E., Thompson V.F., Li H., Wei W., Cong J. The calpain system. Physiol. Rev. 2003, 83:731-801.
19. Grant R.J., Sellings L.H., Crocker S.J., Melloni E., Park D.S., Clarke P.B. Effects of calpain inhibition on dopaminergic markers and motor function following intrastriatal 6-hydroxydopamine administration in rats. Neuroscience 2009, 158:558-569.
20. Hanna R.A., Campbell R.L., Davies P.L. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin. Nature 2008, 456:409-412.
21. Hoopfer E.D., McLaughlin T., Watts R.J., Schuldiner O., O'Leary D.D., Luo L. Wlds protection distinguishes axon degeneration following injury from naturally occurring developmental pruning. Neuron 2006, 50:883-895.
22. Jänicke R.U., Ng P., Sprengart M.L., Porter A.G. Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J.Biol. Chem. 1998, 273:15540-15545.
23. Johnson V.E., Stewart W., Smith D.H. Axonal pathology in traumatic brain injury. Exp. Neurol. 2012.
24. Kato M., Nonaka T., Maki M., Kikuchi H., Imajoh-Ohmi S. Caspases cleave the amino-terminal calpain inhibitory unit of calpastatin during apoptosis in human Jurkat Tcells. J.Biochem. 2000, 127:297-305.
25. Liu X., Van Vleet T., Schnellmann R.G. The role of calpain in oncotic cell death. Annu. Rev. Pharmacol. Toxicol. 2004, 44:349-370.
26. LoPachin R.M., Lehning E.J. Mechanism of calcium entry during axon injury and degeneration. Toxicol. Appl. Pharmacol. 1997, 143:233-244.
27. Lunn E.R., Perry V.H., Brown M.C., Rosen H., Gordon S. Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve. Eur. J. Neurosci. 1989, 1:27-33.
28. Luo L., O'Leary D.D. Axon retraction and degeneration in development and disease. Annu. Rev. Neurosci. 2005, 28:127-156.
29. Ma M., Ferguson T.A., Schoch K.M., Li J., Qian Y., Shofer F.S., Saatman K.E., Neumar R.W. Calpains mediate axonal cytoskeleton disintegration during Wallerian degeneration. Neurobiol. Dis. 2013, 56:34-46.
30. MacInnis B.L., Campenot R.B. Regulation of Wallerian degeneration and nerve growth factor withdrawal-induced pruning of axons of sympathetic neurons by the proteasome and the MEK/Erk pathway. Mol. Cell. Neurosci. 2005, 28:430-439.
31. Mack T.G., Reiner M., Beirowski B., Mi W., Emanuelli M., Wagner D., Thomson D., Gillingwater T., Court F., Conforti L., et al. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat. Neurosci. 2001, 4:1199-1206.
32. Mellgren R.L. Specificities of cell permeant peptidyl inhibitors for the proteinase activities of mu-calpain and the 20S proteasome. J.Biol. Chem. 1997, 272:29899-29903.
33. Nakamura M., Inomata M., Imajoh S., Suzuki K., Kawashima S. Fragmentation of an endogenous inhibitor upon complex formation with high- and low-Ca2+-requiring forms of calcium-activated neutral proteases. Biochemistry 1989, 28:449-455.
34. Neumar R.W., Xu Y.A., Gada H., Guttmann R.P., Siman R. Cross-talk between calpain and caspase proteolytic systems during neuronal apoptosis. J.Biol. Chem. 2003, 278:14162-14167.
35. Nikolaev A., McLaughlin T., O'Leary D.D., Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009, 457:981-989.
36. Osterloh J.M., Yang J., Rooney T.M., Fox A.N., Adalbert R., Powell E.H., Sheehan A.E., Avery M.A., Hackett R., Logan M.A., et al. dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science 2012, 337:481-484.
37. Pörn-Ares M.I., Samali A., Orrenius S. Cleavage of the calpain inhibitor, calpastatin, during apoptosis. Cell Death Differ. 1998, 5:1028-1033.
38. Posmantur R.M., Zhao X., Kampfl A., Clifton G.L., Hayes R.L. Immunoblot analyses of the relative contributions of cysteine and aspartic proteases to neurofilament breakdown products following experimental brain injury in rats. Neurochem. Res. 1998, 23:1265-1276.
39. Rao M.V., Mohan P.S., Peterhoff C.M., Yang D.S., Schmidt S.D., Stavrides P.H., Campbell J., Chen Y., Jiang Y., Paskevich P.A., et al. Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression. J.Neurosci. 2008, 28:12241-12254.
40. Sasaki Y., Milbrandt J. Axonal degeneration is blocked by nicotinamide mononucleotide adenylyltransferase (Nmnat) protein transduction into transected axons. J.Biol. Chem. 2010, 285:41211-41215.
41. Sasaki Y., Vohra B.P., Baloh R.H., Milbrandt J. Transgenic mice expressing the Nmnat1 protein manifest robust delay in axonal degeneration invivo. J.Neurosci. 2009, 29:6526-6534.
42. Schlaepfer W.W. Calcium-induced degeneration of axoplasm in isolated segments of rat peripheral nerve. Brain Res. 1974, 69:203-215.
43. Shin J.E., Miller B.R., Babetto E., Cho Y., Sasaki Y., Qayum S., Russler E.V., Cavalli V., Milbrandt J., DiAntonio A. SCG10 is a JNK target in the axonal degeneration pathway. Proc. Natl. Acad. Sci. USA 2012, 109:E3696-E3705.
44. Simon D.J., Weimer R.M., McLaughlin T., Kallop D., Stanger K., Yang J., O'Leary D.D., Hannoush R.N., Tessier-Lavigne M. A caspase cascade regulating developmental axon degeneration. J.Neurosci. 2012, 32:17540-17553.
45. Takano J., Tomioka M., Tsubuki S., Higuchi M., Iwata N., Itohara S., Maki M., Saido T.C. Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice. J.Biol. Chem. 2005, 280:16175-16184.
46. Vohra B.P., Sasaki Y., Miller B.R., Chang J., DiAntonio A., Milbrandt J. Amyloid precursor protein cleavage-dependent and -independent axonal degeneration programs share a common nicotinamide mononucleotide adenylyltransferase 1-sensitive pathway. J.Neurosci. 2010, 30:13729-13738.
47. Vosler P.S., Gao Y., Brennan C.S., Yanagiya A., Gan Y., Cao G., Zhang F., Morley S.J., Sonenberg N., Bennett M.V., Chen J. Ischemia-induced calpain activation causes eukaryotic (translation) initiation factor 4G1 (eIF4GI) degradation, protein synthesis inhibition, and neuronal death. Proc. Natl. Acad. Sci. USA 2011, 108:18102-18107.
48. Waller A. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibres. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1850, 140:423-429.
49. Wang K.K., Posmantur R., Nadimpalli R., Nath R., Mohan P., Nixon R.A., Talanian R.V., Keegan M., Herzog L., Allen H. Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch. Biochem. Biophys. 1998, 356:187-196.
50. Wang K.K., Posmantur R., Nath R., McGinnis K., Whitton M., Talanian R.V., Glantz S.B., Morrow J.S. Simultaneous degradation of alphaII- and betaII-spectrin by caspase 3 (CPP32) in apoptotic cells. J.Biol. Chem. 1998, 273:22490-22497.
51. Wang J.T., Medress Z.A., Barres B.A. Axon degeneration: molecular mechanisms of a self-destruction pathway. J.Cell Biol. 2012, 196:7-18.
52. Watts R.J., Hoopfer E.D., Luo L. Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system. Neuron 2003, 38:871-885.
53. Whitmore A.V., Lindsten T., Raff M.C., Thompson C.B. The proapoptotic proteins Bax and Bak are not involved in Wallerian degeneration. Cell Death Differ. 2003, 10:260-261.
54. Zhai Q., Wang J., Kim A., Liu Q., Watts R., Hoopfer E., Mitchison T., Luo L., He Z. Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration. Neuron 2003, 39:217-225.